Search results
6 days ago · Based on short-term price targets offered by 12 analysts, the average price target for Iovance Biotherapeutics comes to $25.58. The forecasts range from a low of $19.00 to a high of $34.00.
People also ask
What are Iova share price targets?
Is Iova stock a good buy?
Should you buy iovance Biotherapeutics (Iova) stock?
Is Iova (Iova) a sell?
5 days ago · What is Iovance Biotherapeutics's stock forecast and purchase recommendation? According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Iovance Biotherapeutics is $24.45, with a high forecast of $34.00 and a low forecast of $17.00.
- (844) 978-6257
- 999 SKYWAY ROAD SUITE 150, SAN CARLOS CA, 94070
- contact@marketbeat.com
3 days ago · Their IOVA share price targets range from $17.00 to $34.00. On average, they anticipate the company's stock price to reach $24.45 in the next twelve months. This suggests a possible upside of 204.9% from the stock's current price.
- (650) 260-7120
- 999 SKYWAY ROAD SUITE 150, SAN CARLOS CA, 94070
- achang@troutgroup.com
5 days ago · The 10 analysts with 12-month price forecasts for IOVA stock have an average target of 25.7, with a low estimate of 19 and a high estimate of 34. The average target predicts an increase of 220.45% from the current stock price of 8.02.
Based on 10 Wall Street analysts offering 12 month price targets for Iovance Biotherapeutics in the last 3 months. The average price target is $24.78 with a high forecast of $32.00 and a low forecast of $19.00. The average price target represents a 141.52% change from the last price of $10.26.
2 days ago · What is IOVA's price target? 14 Wall Street analysts currently have issued price targets for IOVA. On average, IOVA’s share price is expected to reach $25.75.
- ADMA Biologics, Inc.
- Biotechnology
- 624
- 2.43B
This price target is based on 10 analysts offering 12 month price targets for Iovance Biotherapeutics in the last 3 months. The average price target is $24.45, with a high forecast of $34.00 and a low forecast of $17.00. The average price target represents a 203.41% upside from the last price of $8.06.
